Bruno Landi

机构：International Drug Development Institute (Belgium), Clinique Saint Jean, Hôpital Saint-Antoine, Centre Jean Bernard

发表论文 124 篇 · 总被引 11493 次 · h-index 33

代表论文

• FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study (2023 · Journal of Clinical Oncology · 被引 192)
• Clinical Relevance of KRAS -Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy (2014 · Clinical Cancer Research · 被引 165)
• Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy (2014 · Clinical Cancer Research · 被引 105)
• Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) (2019 · Digestive and Liver Disease · 被引 83)
• Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS) (2021 · European Journal of Cancer · 被引 58)
• NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients (2016 · OncoImmunology · 被引 56)